Want to see PIII full AI Analyst Report?
Total Valuation
P3 Health Partners has a market cap or net worth of $75.08M. The enterprise value is $374.70.
Market Cap$75.08M
Enterprise Value$374.70
Share Statistics
P3 Health Partners has 3,911,962 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,911,962
Owned by Insiders18.65%
Owned by Institutions1.68%
Financial Efficiency
P3 Health Partners’s return on equity (ROE) is 0.95 and return on invested capital (ROIC) is -172.80%.
Return on Equity (ROE)0.95
Return on Assets (ROA)-0.23
Return on Invested Capital (ROIC)-172.80%
Return on Capital Employed (ROCE)-2.43
Revenue Per Employee4.56M
Profits Per Employee-1.01M
Employee Count320
Asset Turnover2.22
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of P3 Health Partners is ―. P3 Health Partners’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00782
PB Ratio-0.07
Price to Fair Value-0.07
Price to FCF-0.13
Price to Operating Cash Flow-0.27
PEG Ratio0.02
Income Statement
In the last 12 months, P3 Health Partners had revenue of 1.46B and earned -147.95M in profits. Earnings per share was -45.26.
Revenue1.46B
Gross Profit-144.32M
Operating Income-270.30M
Pretax Income-321.06M
Net Income-147.95M
EBITDA-181.86M
Earnings Per Share (EPS)-45.26
Cash Flow
In the last 12 months, operating cash flow was -130.52M and capital expenditures 0.00, giving a free cash flow of -130.40M billion.
Operating Cash Flow-130.52M
Free Cash Flow-130.40M
Free Cash Flow per Share-33.33
Dividends & Yields
P3 Health Partners pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.11
52-Week Price Change43.39%
50-Day Moving Average10.82
200-Day Moving Average6.17
Relative Strength Index (RSI)46.31
Average Volume (3m)7.40K
Important Dates
P3 Health Partners upcoming earnings date is Nov 18, 2026, After Close (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 18, 2026
Ex-Dividend Date―
Financial Position
P3 Health Partners as a current ratio of 0.24, with Debt / Equity ratio of 180.46%
Current Ratio0.24
Quick Ratio0.24
Debt to Market Cap23.96
Net Debt to EBITDA-1.43
Interest Coverage Ratio-4.91
Taxes
In the past 12 months, P3 Health Partners has paid 2.02M in taxes.
Income Tax2.02M
Effective Tax Rate>-0.01
Enterprise Valuation
P3 Health Partners EV to EBITDA ratio is -1.49, with an EV/FCF ratio of -2.97.
EV to Sales0.19
EV to EBITDA-1.49
EV to Free Cash Flow-2.97
EV to Operating Cash Flow-2.97
Balance Sheet
P3 Health Partners has $21.27M in cash and marketable securities with $130.27M in debt, giving a net cash position of -$109.00M billion.
Cash & Marketable Securities$21.27M
Total Debt$130.27M
Net Cash-$109.00M
Net Cash Per Share-$27.86
Tangible Book Value Per Share-$193.53
Margins
Gross margin is 31.65%, with operating margin of -18.53%, and net profit margin of -10.14%.
Gross Margin31.65%
Operating Margin-18.53%
Pretax Margin-22.00%
Net Profit Margin-10.14%
EBITDA Margin-12.46%
EBIT Margin-18.23%
Analyst Forecast
The average price target for P3 Health Partners is $18.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$18.00
Price Target Upside87.11% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast2.81%
EPS Growth Forecast26.63%